Οn the 13th of October this year, the Ministry of Health in Ukraine presented for public discussion the Cabinet of Ministers’ draft legislation named “ Some Issues Concerning The Licensing of Commercial Activity”, the text of which has been published on the Ministry’s official website.
The draft legislation proposes to vest upon the State Administration on Medicinal Products and the State Administration on Drug Control the authority to license commercial activities, which they possessed before the entry into force of the Cabinet of Ministers decree № 609 , dating from 05.08.2015 “ Concerning the recognition of the list of authorities, whose licensing and recognition lost the validity of certain decrees by the Cabinet of Ministers of Ukraine”, before the completion of the transfer of licensing acts to the reorganized State Administration on Medicinal Products and the State Administration on Drug Control.
In particular, according to the draft legislation
It should be reminded that on the 26th August 2015, on the entry into force of the Cabinet of Ministers’ decree № 609 “Concerning the recognition of the list of authorities, whose licensing and recognition lost the validity of certain decrees by the Cabinet of Ministers of Ukraine” the authority of the State Administration on Medicinal Products and the State Administration on Drugs Control as licensing organs of the above mentioned commercial activities was terminated. Instead, the State Authority on Medicinal Products and Drug Control was determined as the new licensing organ, which up until now has not commenced its’ functioning.
Thus, it was determined that a currently nonexistent state organ, is de facto, administering the licensing of the above mentioned commercial activities.
Precisely with the aim of regulating the situation at hand, namely, the prevention of the termination of the licensing procedures of the abovementioned commercial activities, the adoption of the draft legislation , which “continues” the authority, as licensing organs, of the State Administration on Medicinal Products and the State Administration on Drug Control, which are reorganizing until the completion of the transfer of licensing acts to the State Administration of medicinal products and drug control.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.